Tech Company Financing Transactions
OptiNose Funding Round
On 10/7/2015, OptiNose secured $30 million in funding from Avista, Entrepreneurs Fund and WFD Ventures.
Transaction Overview
Company Name
Announced On
10/7/2015
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This round of financing will help drive our clinical research plans to develop OPN-375 globally and for follow-on indications, and will support investment in manufacturing infrastructure and other preparations necessary to support commercialization of OPN-375 in the United States.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
1020 Stony Hill Rd. 300
Yardley, PA 19067
USA
Yardley, PA 19067
USA
Phone
Website
Email Address
Overview
Optinose (Nasdaq: OPtN) creates drug delivery technologies that in essence make good drugs better. We hope to accomplish this by taking aim at one of the healthcare industry's greatest challenges: to efficiently and reliably deliver drugs to targeted, hard to reach areas of the body in order to treat medical conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Miller
Chief Operating Officer
Ramy Mahmoud
Chief Scientific Officer
Per Djupesland
VP - Bus. Development
John Messina
VP - Finance
Michele Janis
VP - Regulatory Affairs
Ramona Lloyd
Browse more venture capital transactions:
Prev: 10/7/2015: SKURT venture capital transaction
Next: 10/7/2015: Netsertive venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs